TWIM
REGN icon

TIAA Wealth Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

TIAA Wealth Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.81K Sell
5
-3
-38% -$2.04K ﹤0.01% 594
2026
Q1 		$6.13K Buy
+8
New +$6.13K ﹤0.01% 527

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

TIAA Wealth Investment Management's REGN Position: Q2 2026 in Review

TIAA Wealth Investment Management reduced its Regeneron Pharmaceuticals (REGN) stake by 38% in Q2 2026, selling an estimated $2.04K and leaving 5 shares worth $2.81K. The position accounts for ﹤0.01% of the portfolio, ranked #594.

TIAA Wealth Investment Management first reported a position in REGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $6.13K in Q1 2026. 1,256 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • TIAA Wealth Investment Management held 5 shares of Regeneron Pharmaceuticals worth $2.81K as of Q2 2026.
  • TIAA Wealth Investment Management sold 3 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.04K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of TIAA Wealth Investment Management's portfolio in Q2 2026, its #594 holding.
  • TIAA Wealth Investment Management first reported a position in Regeneron Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • TIAA Wealth Investment Management's Regeneron Pharmaceuticals position peaked at $6.13K in Q1 2026.
  • 1,256 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on TIAA Wealth Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.